MORGAN STANLEY PLC/CALL/AVANTOR/27.5/0.5/20.12.24 Stock

Warrant

DE000ME9GKK5

Market Closed - Börse Stuttgart 12:50:31 2024-05-15 EDT
0.71 EUR +1.43% Intraday chart for MORGAN STANLEY PLC/CALL/AVANTOR/27.5/0.5/20.12.24
Current month-2.78%
1 month-31.37%
Date Price Change
24-05-15 0.71 +1.43%
24-05-14 0.7 +7.69%
24-05-13 0.65 -10.96%
24-05-10 0.73 +7.35%
24-05-09 0.68 +4.62%

Delayed Quote Börse Stuttgart

Last update May 15, 2024 at 12:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AVANTOR, INC.
Issuer Morgan Stanley
WKN ME9GKK
ISINDE000ME9GKK5
Date issued 2024-03-01
Strike 27.5 $
Maturity 2024-12-20 (219 Days)
Parity 2 : 1
Emission price 1.05
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.19
Lowest since issue 0.6
Delta0.45x
Omega 6.721
Premium15.78x
Gearing14.94x
Moneyness 0.9167
Difference Strike 2.29 $
Difference Strike %+8.33%
Spread 0.05
Spread %6.25%
Theoretical value 0.7750
Implied Volatility 28.98 %
Total Loss Probability 63.71 %
Intrinsic value 0.000000
Present value 0.7750
Break even 29.19 €
Theta-0.02x
Vega0.04x
Rho0.03x

Company Profile

Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Sector
-
More about the company

Ratings for Avantor, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Avantor, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
25.21 USD
Average target price
27.77 USD
Spread / Average Target
+10.14%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW